Literature DB >> 17199431

Estrogen receptor (ER)-beta, but not ER-alpha, is present in thyroid vessels: immunohistochemical evaluations in multinodular goiter and papillary thyroid carcinoma.

Graziano Ceresini1, Simonetta Morganti, Virna Graiani, Maria Saccani, Bruna Milli, Elisa Usberti, Giorgio Valenti, Gian Paolo Ceda, Luigi Corcione.   

Abstract

OBJECTIVE: Estrogen receptors (ERs) have been demostrated in the vessel structures of several systems. Little is known on the presence of ERs in the thyroid vessels.
DESIGN: We immunohistochemically evaluated both ER-alpha and ER-beta immunoreactivity (IR) in both vascular and follicular thyroid cells in tissue samples from 17 cases of multinodular goiter (MNG) and 17 cases of papillary thyroid carcinoma (PTC). MAIN OUTCOME: ER-alpha IR was undetectable in either tissue examined. In 100% of MNG samples, nuclear ER-beta IR was detected in both endothelial and follicular cells. In PTC samples, endothelial nuclear ER-beta IR was found in 100% of cases, whereas the nuclear staining of follicular cells was found in 83% of cases. The intensity of staining of the endothelial ER-beta IR was comparable between MNG and PTC. However, when follicular cells were considered, a tendency toward a decrease in nuclear staining and a significant increase in cytoplasmic staining were found in PTC lesions as compared to MNG.
CONCLUSIONS: This study demonstrated that ER-beta, but not ER-alpha, IR is present in the endothelium of thyroid vessels. Furthermore, although data need to be confirmed in larger observations, these results suggest the lack of differences in the pattern of vascular ER-beta IR between MNG and PTC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17199431     DOI: 10.1089/thy.2006.16.1215

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  6 in total

1.  Are estrogen receptors alpha detectable in normal and abnormal thyroid tissue?

Authors:  Michael Vaiman; Youlian Olevson; Judith Sandbank; Liliana Habler; Sergei Zehavi; Alex Kessler
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-16       Impact factor: 2.503

2.  Reduced expression of oestrogen receptor-β is associated with tumour invasion and metastasis in oestrogen receptor-α-negative human papillary thyroid carcinoma.

Authors:  Wen-Wu Dong; Jian Li; Jing Li; Ping Zhang; Zhi-Hong Wang; Wei Sun; Hao Zhang
Journal:  Int J Exp Pathol       Date:  2018-04-14       Impact factor: 1.925

3.  Expression of sex steroid hormone receptors in C cell hyperplasia and medullary thyroid carcinoma.

Authors:  Claire Bléchet; Pierre Lecomte; Loïc De Calan; Patrice Beutter; Serge Guyétant
Journal:  Virchows Arch       Date:  2007-02-28       Impact factor: 4.064

4.  Papillary Thyroid Cancer-Promoting Activities of Combined Oral Contraceptive Components.

Authors:  Mehdi Hedayati; Sadegh Rajabi; Abdolrahim Nikzamir
Journal:  Galen Med J       Date:  2020-05-21

5.  Role of estrogen in thyroid function and growth regulation.

Authors:  Ana Paula Santin; Tania Weber Furlanetto
Journal:  J Thyroid Res       Date:  2011-05-04

6.  Expression of Estrogen and Progesterone Receptors in Papillary Thyroid Carcinoma in Korea.

Authors:  Hwa Young Ahn; Ra-Yeong Song; Hye Shin Ahn; Hee Sung Kim
Journal:  Cancer Res Treat       Date:  2021-02-10       Impact factor: 4.679

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.